Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
SPJ-Saudi Pharmaceutical Journal. 2009; 17 (2): 148-153
in English | IMEMR | ID: emr-92841

ABSTRACT

The aim of the present study is to investigate the possible role of melatonin, when administered as an eye drops, in the selenite-induced cataractogenesis in rat pups. Sixty Wistar albino rats [13 days old] were allocated into three groups [20 animals each]. group A injected subcutaneously with normal saline and received no other treatment served as control; group B injected with [40 micro mol/g body weight] sodium selenite subcutaneously, and treated with 1 drop of melatonin eye drops, specially formulated for this purpose, twice daily for 30 days; group C injected with sodium selenite as in group B, but treated with single drop of normal saline, twice daily for 30 days. The stage of cataract development was examined with slit-lamp photographs. Alter 30 days the pups were sacrificed and their eyeballs enucleated for histological examination. The results demonstrated that melatonin eye drops decreased the nuclear cataract formation after 15 and 21 days of treatment, compared to saline treated group. Histological evaluations of enucleated lenses revealed that treatment with melatonin drops clearly indicated recovery of the lenticular tissues and retained their ordinary shape. These findings demonstrate that melatonin when administered as an eye drops protects the lens of rat pups against selenite-induced cataract


Subject(s)
Animals, Laboratory , Sodium Selenite/adverse effects , Ophthalmic Solutions , Cataract/prevention & control , Rats, Sprague-Dawley , Lens, Crystalline
SELECTION OF CITATIONS
SEARCH DETAIL